Loss of DARPP-32 and calbindin in multiple system atrophy

Journal of Neural Transmission

Volumn 120, Issue 12, 2013, Pages 1689-1698

  Hayakawa, Hideki ^a   Nagai, Makiko ^b   Kawanami, Aya ^b   Nakata, Yasuto ^a   Nihira, Tomoko ^a   Ogino, Mieko ^b   Takada, Masahiko ^c   Saido, Takaomi ^d   Takano, Jiro ^d   Saegusa, Makoto ^b   Mikami, Tetsuo ^b   Hamada, Junichi ^b   Nishiyama, Kazutoshi ^b   Mochizuki, Hideki ^e   Mizuno, Yoshikuni ^a  

^a KITASATO UNIVERSITY   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^e OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Calbindin D 28k; DARPP 32; Glial cytoplasmic inclusion; Multiple system atrophy; Pathogenesis

Indexed keywords

ALPHA SYNUCLEIN; CALBINDIN; CALPAIN; DOPAMINE; PHOSPHOPROTEIN DARPP 32; SPECTRIN; TYROSINE 3 MONOOXYGENASE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; AUTONOMIC DYSFUNCTION; BRAIN CELL; BRAIN CORTEX; BRAIN HEMORRHAGE; BRONCHOPNEUMONIA; CELL LOSS; CEREBELLAR ATAXIA; CEREBELLUM CORTEX; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CONTROL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; OLIGODENDROGLIA; PARKINSONISM; PATHOGENESIS; PONTINE NUCLEUS; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN PHOSPHORYLATION; PURKINJE CELL; PUTAMEN; PYRAMIDAL SIGN; PYRAMIDAL TRACT; SHY DRAGER SYNDROME; SLEEP DISORDERED BREATHING; SUBSTANTIA NIGRA; WHITE MATTER;

AGED; AGED, 80 AND OVER; ALPHA-SYNUCLEIN; BRAIN; CALBINDIN 1; CASE-CONTROL STUDIES; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; TYROSINE 3-MONOOXYGENASE;

EID: 84890559827     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-013-1039-4     Document Type: Article

References (34)

1. Adams R, VanBogaert L, Vandereecken H (1964) Striato-nigral degeneration. J Neruopathol Exp Neurol 23:584-608
2. Bertran-Gonzalez J, Bosch C, Maroteaux M, Matamales M, Herve D, Valjent E, Girault JA (2008) Opposing patterns of signaling activation in dopamine D1 and D2 receptor-expressing striatal neurons in response to cocaine and haloperidol. J Neurosci 28:5671-5685. doi: 10.1523/JNEUROSCI.1039-08.2008
3. Damier P, Hirsch EC, Agid Y, Graybiel AM (1999) The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D (28K) immunohistochemistry. Brain 122:1421-1436
4. DiFiglia M, Christakos S, Aronin N (1989) Ultrastructural localization of immunoreactive calbindin-D 28k in the rat and monkey basal ganglia, including subcellular distribution with colloidal gold labeling. J Comp Neurol 279:653-665. doi: 10.1002/cne.902790411
5. Farre-Castany MA, Schwaller B, Gregory P, Barski J, Mariethoz C, Eriksson JL, Tetko IV, Wolfer D, Celio MR, Schmutz I, Albrecht U, Villa AE (2007) Differences in locomotor behavior revealed in mice deficient for the calcium-binding proteins parvalbumin, calbindin D-28k or both. Behav Brain Res 178:250-261. doi: 10.1016/j.bbr.2007.01.002
6. Fienberg AA, Greengard P (2000) The DARPP-32 knockout mouse. Brain Res Brain Res Rev 31:313-319
7. Garcia-Segura LM, Baetens D, Roth J, Norman AW, Orci L (1984) Immunohistochemical mapping of calcium-binding protein immunoreactivity in the rat central nervous system. Brain Res 296:75-86
8. Girault JA, Raisman-Vozari R, Agid Y, Greengard P (1989) Striatal phosphoproteins in Parkinson disease and progressive supranuclear palsy. Proc Natl Acad Sci USA 86:2493-2497
9. Greengard P, Allen PB, Nairn AC (1999) Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade. Neuron 23:435-447
10. Honjo Y, Shirakashi Y, Kawamoto Y, Akiguchi I (2008) Anti-DARPP32 antibody-immunopositive inclusions in the brain of patients with multiple system atrophy. Clin Neuropathol 27:309-316
11. Ichimiya Y, Emson PC, Mountjoy CQ, Lawson DE, Heizmann CW (1988) Loss of calbindin-28K immunoreactive neurones from the cortex in Alzheimer-type dementia. Brain Res 475:156-159
12. Inoue M, Yagishita S, Ryo M, Hasegawa K, Amano N, Matsushita M (1997) The distribution and dynamic density of oligodendroglial cytoplasmic inclusions (GCIs) in multiple system atrophy: a correlation between the density of GCIs and the degree of involvement of striatonigral and olivopontocerebellar systems. Acta Neuropathol 93:585-591
13. Ishikawa K, Mizusawa H, Fujita T, Ohkoshi N, Doi M, Komatsuzaki Y, Iwamoto H, Ogata T, Shoji S (1995) Calbindin-D 28k immunoreactivity in the cerebellum of spinocerebellar degeneration. J Neurol Sci 129:179-185
14. Ito H, Goto S, Sakamoto S, Hirano A (1992) Calbindin-D 28k in the basal ganglia of patients with Parkinsonism. Ann Neurol 32(4):543-550
15. Karachi C, Francois C, Parain K, Bardinet E, Tande D, Hirsch E, Yelnik J (2002) Three-dimensional cartography of functional territories in the human striatopallidal complex by using calbindin immunoreactivity. J Comp Neurol 450:122-134. doi: 10.1002/cne.10312
16. Masui K, Nakata Y, Fujii N, Iwaki T (2012) Extensive distribution of glial cytoplasmic inclusions in an autopsied case of multiple system atrophy with a prolonged 18-year clinical course. Neuropathology 32:69-76. doi: 10.1111/j.1440-1789.2011.01222.x
17. McLachlan DR, Wong L, Bergeron C, Baimbridge KG (1987) Calmodulin and calbindin D 28K in Alzheimer disease. Alzheimer Dis Assoc Disord 1:171-179
18. McRitchie DA, Halliday GM (1995) Calbindin D 28k-containing neurons are restricted to the medial substantia nigra in humans. Neuroscience 65(1):87-91
19. Nakazato Y, Yamazaki H, Hirato J, Ishida Y, Yamaguchi H (1990) Oligodendroglial microtubular tangles in olivopontocerebellar atrophy. J Neuropathol Exp Neurol 49:521-530
20. Onn SP, Fienberg AA, Grace AA (2003) Dopamine modulation of membrane excitability in striatal spiny neurons is altered in DARPP-32 knockout mice. J Pharmacol Exp Ther 306:870-879. doi: 10.1124/jpet.103.050062
21. Ouimet CC, Miller PE, Hemmings HC Jr, Walaas SI, Greengard P (1984) DARPP-32, a dopamine- and adenosine 3′:5′-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization. J Neurosci 4:111-124
22. Ozawa T, Paviour D, Quinn NP, Josephs KA, Sangha H, Kilford L, Healy DG, Wood NW, Lees AJ, Holton JL, Revesz T (2004) The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. Brain 127:2657-2671. doi: 10.1093/brain/awh303
23. Papp MI, Kahn JE, Lantos PL (1989) Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci 94:79-100
24. Raisman-Vozari R, Girault JA, Moussaoui S, Feuerstein C, Jenner P, Marsden CD, Agid Y (1990) Lack of change in striatal DARPP-32 levels following nigrostriatal dopaminergic lesions in animals and in parkinsonian syndromes in man. Brain Res 507:45-50
25. Saido TC, Yokota M, Nagao S, Yamaura I, Tani E, Tsuchiya T, Suzuki K, Kawashima S (1993) Spatial resolution of fodrin proteolysis in postischemic brain. J Biol Chem 268:25239-25243
26. Sato K, Kaji R, Matsumoto S, Nagahiro S, Goto S (2007) Compartmental loss of striatal medium spiny neurons in multiple system atrophy of parkinsonian type. Mov Disord 22:2365-2370. doi: 10.1002/mds.21732
27. Séquier JM, Hunziker W, Richards G (1988) Localization of calbindin D 28 mRNA in rat tissues by in situ hybridization. Neurosci Lett 86:155-160
28. Servais L, Bearzatto B, Schwaller B, Dumont M, De Saedeleer C, Dan B, Barski JJ, Schiffmann SN, Cheron G (2005) Mono- and dual-frequency fast cerebellar oscillation in mice lacking parvalbumin and/or calbindin D-28k. Eur J Neurosci 22:861-870. doi: 10.1111/j.1460-9568.2005.04275.x
29. Seto-Ohshima A, Emson PC, Lawson E, Mountjoy CQ, Carrasco LH (1988) Loss of matrix calcium-binding protein-containing neurons in Huntington's disease. Lancet 8597:1252-1255
30. Taniguchi S, Fujita Y, Hayashi S, Kakita A, Takahashi H, Murayama S, Saido TC, Hisanaga S, Iwatsubo T, Hasegawa M (2001) Calpain-mediated degradation of p35 to p25 in postmortem human and rat brains. FEBS Lett 489:46-50
31. Wakabayashi K, Yoshimoto M, Tsuji S, Takahashi H (1998) Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci Lett 249:180-182
32. Walaas SI, Greengard P (1984) DARPP-32, a dopamine- and adenosine 3′:5′-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. I. Regional and cellular distribution in the rat brain. J Neurosci 4:84-98
33. Wenning GK, Tison F, Ben Shlomo Y, Daniel SE, Quinn NP (1997) Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord 12:133-147. doi: 10.1002/mds.870120203
34. Wüllner U, Weller M, Kornhuber J, Bornemann A, Schulz JB, Riederer P, Klockgether T (2000) Altered expression of calcium- and apoptosis-regulating proteins in multiple system atrophy Purkinje cells. Mov Disord 15:269-275